ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658103; 2) Community: the network communities that were significantly associated with the response to NSC 658103; 3) Molecule: the relationships between components within communities and NSC 658103; 4) MDR: the compounds that were significantly associated with the NSC 658103.

NSC Compound Enrichment Correlation
NSC 732825 N1-(4-methoxyphenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihy dro-1H-3-pyrrolylamino)benzamide 0.0164116791870036 0.42095307
NSC 746930 Null 0.0164116791870036 0.19268246
NSC 758617 Atorvastatin calcium (USAN) 0.0164116791870036 0.23508236
NSC 759878 Irinotecan hydrochloride (USAN) 0.0164116791870036 0.64843095
NSC 660027 Null 0.017498903403062 0.49550668
NSC 666112 Null 0.017498903403062 0.38718962
NSC 666850 Null 0.017498903403062 0.24784459
NSC 67586 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, 0.017498903403062 0.38834819
NSC 677696 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester 0.017498903403062 0.24312164
NSC 681643 Camptothecin Derivative 0.017498903403062 0.64985487
Total:83  Current:27    [First] [Prev] [Next] [Last]